Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
(July 2000)
Connectivity maps for biosimilar drug discovery in venoms: the case of Gila monster venom and the anti-diabetes drug Byetta
Separately, the pharmas have sued several pharmacies and clinics which they allege are illegally producing compounded versions of their incretin products
Legal permissibility depends on strict adherence to FDA guidance and Section 503A of the Federal Food, Drug, and Cosmetic Act
US$ 26.39
US$ 29.23
US$ 29.21
US$ 23.97
US$ 29.92
